Tell Patients Clopidogrel Doesn't Increase Mortality

We're getting questions about the efficacy of long-term clopidogrel (Plavix, etc)...due to a new report from FDA.

This started because of a study suggesting that coronary stent patients on clopidogrel plus aspirin have a higher risk of death.

The good news is that this risk doesn't pan out when data from several trials are combined.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals